Shuji Tohda Selected Research

Shuji Tohda Research Topics

Disease

20	Leukemia 06/2020 - 05/2003
12	Neoplasms (Cancer) 06/2020 - 08/2006
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2020 - 05/2005
8	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2020 - 11/2006
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2020 - 07/2007
6	Lymphoma (Lymphomas) 11/2017 - 09/2005
4	Infections 02/2020 - 03/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
3	Myeloid Leukemia (Leukemia, Myelocytic) 09/2018 - 08/2004
3	Thymoma (Thymic Carcinoma) 01/2018 - 03/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2017 - 11/2006
3	Chronic Hepatitis C 10/2017 - 11/2016
2	COVID-19 09/2022 - 01/2021
2	Hemorrhage 01/2021 - 04/2006
2	Hypoxia (Hypoxemia) 08/2019 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 06/2014
2	Sepsis (Septicemia) 06/2014 - 03/2012
2	Polycythemia Vera 01/2014 - 08/2012
2	Thrombocytopenia (Thrombopenia) 01/2014 - 01/2008
2	Multiple Myeloma 04/2009 - 08/2006
1	Pneumoperitoneum 01/2022
1	Cholelithiasis 01/2022
1	Meningococcal Infections 01/2022
1	Hypertension (High Blood Pressure) 06/2021
1	Atherosclerosis 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Carcinogenesis 06/2020
1	Pemphigus (Pemphigus Vulgaris) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Bronchiolitis 01/2019
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019
1	Bronchiolitis Obliterans 01/2019
1	Glioma (Gliomas) 11/2018
1	X-linked Reticuloendotheliosis 11/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2005
9	LigandsIBA 09/2015 - 05/2003
5	Sirolimus (Rapamycin)FDA Link 08/2019 - 03/2013
5	Gamma Secretase Inhibitors and ModulatorsIBA 10/2010 - 11/2006
3	NF-kappa B (NF-kB)IBA 08/2019 - 09/2009
3	Ribavirin (Virazole)FDA LinkGeneric 10/2017 - 11/2016
3	Prednisolone (Predate)FDA LinkGeneric 04/2016 - 02/2002
3	Messenger RNA (mRNA)IBA 06/2014 - 07/2007
3	Notch1 ReceptorIBA 09/2012 - 11/2009
3	2- (2- (3,5- difluorophenyl)- acetylamino)- N- (1- methyl- 2- oxo- 5- phenyl- 2,3- dihydro- 1H- benzo(e)(1,4)diazepin- 3- yl)propionamideIBA 03/2011 - 02/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2020
2	fibrin fragment D (D-dimer)IBA 06/2021 - 01/2021
2	HDL LipoproteinsIBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 08/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2005
2	c-Mer Tyrosine KinaseIBA 01/2020 - 01/2018
2	Small Interfering RNA (siRNA)IBA 08/2018 - 10/2013
2	Pharmaceutical PreparationsIBA 10/2017 - 09/2005
2	InterferonsIBA 01/2017 - 11/2016
2	16S Ribosomal RNAIBA 06/2014 - 03/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2011 - 10/2010
2	cyclopamineIBA 03/2011 - 11/2009
2	QuercetinIBA 03/2011 - 11/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2005 - 02/2002
1	A-factor (Streptomyces)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 09/2022
1	HomocysteineIBA 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	polyacrylamideIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Sirtuin 1IBA 06/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	dubermatinibIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Axl Receptor Tyrosine KinaseIBA 01/2020
1	beta-lactamase PSE-2IBA 01/2019
1	Desmoglein 1IBA 01/2019
1	AntibodiesIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	CateninsIBA 11/2018
1	GlycosyltransferasesIBA 09/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	artemisinin (artemisinine)IBA 11/2017
1	NF-kappaB-Inducing KinaseIBA 11/2017
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2017
1	PTC-209IBA 11/2017
1	2- pyridine- 3- yl- methylene- indan- 1,3- dioneIBA 11/2017
1	ST2825IBA 11/2017

Therapy/Procedure

17	Therapeutics 01/2021 - 08/2006
3	Molecular Targeted Therapy 01/2017 - 03/2011
2	Drug Therapy (Chemotherapy) 07/2007 - 02/2002
1	Intravenous Anesthesia 01/2022
1	Laparoscopic Cholecystectomy 01/2022
1	Orthopedic Procedures 01/2021